Market Cap | 14.68M | P/E | - | EPS this Y | 46.70% | Ern Qtrly Grth | - |
Income | -1.29M | Forward P/E | - | EPS next Y | 112.50% | 50D Avg Chg | -8.00% |
Sales | 13.77M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 11.00% |
Dividend | N/A | Price/Book | 1.65 | EPS next 5Y | - | 52W High Chg | -44.00% |
Recommedations | 2.00 | Quick Ratio | 2.54 | Shares Outstanding | 10.54M | 52W Low Chg | 54.00% |
Insider Own | 12.75% | ROA | -7.96% | Shares Float | 5.64M | Beta | 1.19 |
Inst Own | 40.98% | ROE | -15.61% | Shares Shorted/Prior | 3.52K/2.05K | Price | 1.40 |
Gross Margin | 60.38% | Profit Margin | -9.40% | Avg. Volume | 79,900 | Target Price | - |
Oper. Margin | -9.75% | Earnings Date | Nov 6 | Volume | 4,314 | Change | -0.71% |
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Benchmark | Speculative Buy | May 15, 24 |
Benchmark | Speculative Buy | Mar 8, 24 |
B. Riley Securities | Buy | Jan 26, 21 |
Benchmark | Speculative Buy | Oct 24, 19 |
Maxim Group | Buy | Oct 4, 19 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Astor Andrew | President, CEO & CFO President, CEO & CFO | Mar 05 | Option | 2.70 | 14,815 | 40,000 | 92,773 | 03/07/22 |